Innova Captab Ltd Share Price Today

Innova Captab Ltd Share Price

Overview

Innova Captab Ltd share price is currently ₹1,156.18, up by ₹43.32 (3.89%) from its previous closing price of ₹1,112.86. The share price has gained 22.51% over the past month and gained 29.04% over the past year. The stock's 52-week low and high are ₹0.00 and ₹1,181.20, respectively. Innova Captab Ltd has a market capitalisation of ₹ 6,040.00 Cr. The share price was last updated on 04 Sep 2026, 03:51 PM IST.

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 20% at ₹2/Share	30-Jan-2026	30-Jan-2026

Actions

Ex-Date

Record-Date

DividendsInterim Dividend of 20% at ₹2/Share

30-Jan-2026

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Kotak Multicap Fund - Regular Plan - Growth	17.89 Lac	17.40 Lac (2.71%)
Canara Robeco Small Cap Fund - Regular Plan - Growth	16.30 Lac	16.30 Lac no change
Invesco India Smallcap Fund - Regular Plan - Growth	6.30 Lac	6.30 Lac no change
Canara Robeco Manufacturing Fund - Regular Plan - Growth	2.72 Lac	2.72 Lac no change
Bandhan Small Cap Fund - Regular Plan - Growth	2.62 Lac	2.58 Lac (1.5%)

Mutual Fund Holder

Jun 26

Shares held

Jul 26

Shares held

Kotak Multicap Fund - Regular Plan - Growth

17.89 Lac

17.40 Lac

(2.71%)

Canara Robeco Small Cap Fund - Regular Plan - Growth

16.30 Lac

no change

Invesco India Smallcap Fund - Regular Plan - Growth

6.30 Lac

no change

Canara Robeco Manufacturing Fund - Regular Plan - Growth

2.72 Lac

no change

Bandhan Small Cap Fund - Regular Plan - Growth

2.62 Lac

2.58 Lac

(1.5%)

CA Sumit Mangla

3 Sep • 1:42 PM · SEBI-Registered Analyst

Innova Captab Board OKs ₹50 Cr Land Acquisition

INNOVACAP

Board of Directors has accorded in-principle approval for the acquisition of land with an estimated investment of approximately ₹50 crore. The proposed land purchase forms part of the company’s strategic real estate expansion and plans for operational facility development. The Board will provide further updates once the final purchase or sale agreement is executed between the parties. This move aligns with Innova Captab’s broader growth strategy in the pharmaceutical manufacturing and CDMO space, aimed at supporting future capacity needs and strengthening its operational footprint. The in-principle clearance marks an important step towards enhancing the company’s long-term manufacturing and infrastructure capabilities. **Top stocks in the pharmaceuticals / CDMO industry:** Laurus Labs, Syngene International, and Divi’s Laboratories.

Kundan Motwani

23 Jan • 1:42 PM · SEBI-Registered Analyst

INNOVA CAPTAB

Q3 CONS NET PROFIT 421M RUPEES VS 342M (YOY) INNOVA CAPTAB: Q3 EBITDA 693M RUPEES VS 466M (YOY) || Q3 EBITDA MARGIN 15.4% VS 14.72% (YOY)

INNOVACAP

Rajneesh Sharma CFTe

19 Jan • 11:23 PM · SEBI-Registered Analyst

Innova Captab Limited (Weekly) – Breakdown Phase with Weak Momentum

INNOVACAP

Trend Structure Price has slipped out of its earlier consolidation range Lower highs and lower lows now visible on the weekly chart Structure indicates distribution rather than accumulation Support & Price Behavior Previous support zone has been broken decisively Breakdowns have been sharper than pullback rallies Earlier support is likely to act as overhead supply now Momentum (RSI) RSI is in oversold territory No bullish divergence visible at this stage Weak RSI aligns with price, indicating trend continuation risk Volume & Participation Selling pressure dominates on down weeks No clear evidence of strong demand absorption yet Overall View Trend remains weak and unbalanced Chart suggests patience until stabilization or momentum improvement appears 📢 Disclaimer: For educational and technical analysis purposes only; not investment advice. 👤 Rajneesh Sharma – SEBI Registered Research Analyst (INH000020332)

Adarsh Nimborkar (SEBI IA)

19 Jan • 12:17 PM · SEBI-Registered Analyst

Innova Captab Ltd — Fundamental Overview

INNOVACAP

Innova Captab Ltd is an Indian integrated pharmaceutical company operating across the value chain of research, development, manufacturing and marketing of pharmaceutical formulations. The company has a diversified business model that includes contract development and manufacturing (CDMO) services for other pharma companies, its own branded generic formulations for the domestic market, and exports to international markets. The company’s strength lies in its integrated setup and diversified revenue streams. CDMO services provide relatively stable volumes through long-term client relationships, while branded generics offer higher margins but are more competitive and marketing-intensive. This combination helps balance risk, as dependency on a single segment is reduced. Financial performance is driven by product mix, capacity utilisation, regulatory approvals and client demand. As a growing pharma manufacturer, earnings can fluctuate due to timing of new product launches, scale-up of CDMO contracts and changes in export demand. Working capital requirements are moderate but important, as receivables from pharma clients and inventory management directly impact cash flows. The pharmaceutical sector offers structural long-term demand, supported by ageing populations, rising chronic diseases and increasing outsourcing of manufacturing by global pharma companies. Innova Captab benefits from these trends, especially as companies look for reliable Indian partners with compliant facilities and cost efficiency. Margins can be sensitive to raw-material costs, compliance expenses and pricing pressure, particularly in highly competitive generic segments. Any regulatory non-compliance or delays in approvals can impact growth momentum. Continuous investment in quality systems, R&D and capacity expansion is therefore critical to remain competitive.

THREETREND RESEARCH

3 Dec • 8:20 AM · SEBI-Registered Analyst

The Most Impressive Earnings Performers in Small Caps! 📊 - Datamatics Global - R Systems International - Swaraj Engines - Kennametal India - VRL Logistics - Ashoka Buildcon - KNR Construction - Capillary Technologies - Electronics Mart - Goldiam International - Shoppers Stop - Pace Digitek - Refex Industries - Sunflag Iron - Goodluck India - Borosil - Aarti Drugs - Innova Captab - Zota Health Care - Suven Life Sciences

SUVEN

SASI KUMAR SEBI RA

21 Aug • 8:13 AM · SEBI-Registered Analyst

Stocks to Watch – 21 August 2025

Earnings Update: • Shanti Gold International: Profit jumped 174% YoY to ₹24.6 Cr vs ₹9 Cr; revenue up 22% to ₹292.8 Cr. Key Market Moves: • Clean Science: Promoters may sell 24% stake (~₹2,626 Cr) via block deals at ₹1,030/share floor price. • India Cements: UltraTech to sell 6.49% stake through OFS at ₹368/share. Opens Aug 21 (non-retail), Aug 22 (retail). • RailTel: Secured two orders worth ₹50 Cr from Kerala IT Mission and Odisha Govt. • Jupiter Wagons: Subsidiary wins ₹215 Cr LOI to supply 5,376 wheelsets for Vande Bharat trains. • Exide: Invested ₹100 Cr in Exide Energy Solutions; total investment now ₹3,802 Cr. • Fortis Healthcare: Ties up with Ekana Group to operate a 550-bed hospital in Lucknow. • Innova Captab: Cleared UK-MHRA inspection for its Baddi plant with no major observations. • Poly Medicure: NCLT approves its resolution plan for Himalayan Mineral Waters. • V-Guard: ICICI Pru MF buys 41.5 lakh shares (0.95% stake) at ₹370/share worth ₹153.6 Cr. Other Notable Updates: • Titan: Director P B Balaji resigned. • Godrej Properties: Buying 7% stake in Godrej Skyline Developers. • Hitachi Energy India: Appointed new Chairman Ismo Antero Haka. • Nucleus Software: Vishnu R Dusad named Interim CFO. • SMC Global: Investing ₹15 Cr in NCDEX. • Crisil: To set up subsidiary in Canada. • Super Iron Foundry: To set up new foundry in Saudi Arabia. • Prostarm Info Systems: L-1 bidder for 150 MW/300 MWh battery storage system in Karnataka. • RACL Geartech: Received long-term order for premium motorcycle gears. Bulk Deals: • Shaily Engineering Plastics: Capital Group funds bought shares worth ₹147.9 Cr, Lighthouse sold shares worth ₹96.25 Cr. • HealthCare Global: Axis MF bought ~1% stake for ₹91.9 Cr. • Sampann Utpadan: Isquare PE Fund acquired 1.8% stake at ₹32.4/share.

Innova Captab Ltd Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Innova Captab Ltd 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Innova Captab Ltd?

What is the market cap of Innova Captab Ltd?

Should I buy Innova Captab Ltd stock now?

What is the 52 week high and low of Innova Captab Ltd?

Is the Innova Captab Ltd stock good to buy?

Is Innova Captab Ltd a good buy for the long term?

Is Innova Captab Ltd overvalued or undervalued?

What is the PE and PB ratio of Innova Captab Ltd?